Published on in Vol 7, No 2 (2015):

Role of Pharmacovigilance in India: An overview

Role of Pharmacovigilance in India: An overview

Role of Pharmacovigilance in India: An overview

Authors of this article:

Sanvidhan G Suke1 ;   Prabhat Kosta2 ;   Harsh Negi3
The full text of this article is available as a PDF download by clicking here.

Journals

  1. TOSUN N, YILDIZ S. Examining The Effects of Covid-19 On Health Services Marketing Research with A Bibliometric Analysis. International Journal of Health Management and Tourism 2021 View
  2. Alsbou M, Batarseh A, Bawaresh N, Jaber J, Qawasmi G, Banat H. Analysis of Antineoplastics, Immunomodulators, Antibiotics and Analgesics Adverse Drug Reactions Reports Submitted to the Pharmacovigilance Database in Jordan. Biosciences, Biotechnology Research Asia 2017;14(2):541 View
  3. Sharma A, Chhabra K, Rajesh G, Binnal A, Chhabra C, Goyal A. Pharmacovigilance: The Least Understood and Least Practiced Science in Dentistry. World Journal of Dentistry 2019;10(5):402 View
  4. Patel C, Kumar S, Rawal R, Patel D, Gonzalez F, Pandya H. A multiparametric organ toxicity predictor for drug discovery. Toxicology Mechanisms and Methods 2020;30(3):159 View
  5. Kopciuch D, Kus K, Fliciński J, Steinborn B, Winczewska-Wiktor A, Paczkowska A, Zaprutko T, Ratajczak P, Nowakowska E. Pharmacovigilance in Pediatric Patients with Epilepsy Using Antiepileptic Drugs. International Journal of Environmental Research and Public Health 2022;19(8):4509 View
  6. Prakash N, Chandran L, Sivakumar M, Pratap Singh A. Perspectives of Artificial Intelligence (AI) in Health Care Management: Prospect and Protest. The Chinese Journal of Artificial Intelligence 2022;1(2) View
  7. Shukla S, Sharma P, Gupta P, Pandey S, Agrawal R, Rathour D, Kumar Kewat D, Singh R, Kumar Thakur S, Paliwal R, Sulakhiya K. Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India. Current Drug Safety 2024;19(2):172 View
  8. Munshi R, Maurya M, Pawaskar P. Public Awareness and Perception about Drug Safety in the Population Residing in Western India - A Questionnaire Based Cross Sectional Survey.. Biomedical and Pharmacology Journal 2022;15(4):1937 View
  9. Kumar Mall S, Dipa P, Goswami S, Singh P, Pal Singh R. Pharmacovigilance programme in India (PvPI): History, Current scenario, future aspects and role in COVID 19. Asian Journal of Research in Pharmaceutical Sciences 2022:205 View
  10. Pant J, Marwah H, Singh R, Hazra S. An overview of the worldwide master key for pharmacovigilance and its role in India. Journal of Pharmacovigilance and Drug Research 2021;2(2):19 View
  11. Tran V, Tran T, Vo Q, Pham K, Dewey R, Van C, Dorofeeva V. A Survey of Pharmacists and Other Healthcare Professionals in Vietnam: Factors Influencing Knowledge and Attitudes Toward Reporting Adverse Drug Reactions. Hospital Pharmacy 2024;59(1):56 View
  12. Abdulrasool Z. The development of a pharmacovigilance system in Bahrain. Saudi Pharmaceutical Journal 2022;30(6):825 View
  13. Kitisopee T, Assanee J, Sorofman B, Watcharadmrongkun S. Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception. Journal of Pharmaceutical Policy and Practice 2022;15(1) View
  14. Rukmangathen R, Brahmanapalli V. Pharmacovigilance study in geriatric patients of a tertiary care hospital. Journal of Pharmacovigilance and Drug Research 2021;2(2):33 View
  15. Verman S, Anjankar A. A Narrative Review of Adverse Event Detection, Monitoring, and Prevention in Indian Hospitals. Cureus 2022 View
  16. Abraham N, Tesfagaber M, Tesfamariam S. Stakeholders’ Perspective on the Integration of Pharmacovigilance Activities into the Eritrean Healthcare System: A Qualitative Study. Risk Management and Healthcare Policy 2023;Volume 16:747 View
  17. Satwika M, Sushma D, Jaiswal V, Asha S, Pal T. The Role of Advanced Technologies Supplemented with Traditional Methods in Pharmacovigilance Sciences. Recent Patents on Biotechnology 2021;15(1):34 View
  18. Jankar B, Gosavi D, Mishra K, Sathe H. Adverse Drug Reactions in the Bipolar Disorder Patients Treated With Mood Stabilizers. Annals of Indian Psychiatry 2024;8(1):45 View
  19. Dylan Fernandes S, Anoop N, Castelino L, Narayana Charyulu R. A national approach to pharmacovigilance: The case of India as a growing hub of global clinical trials. Research in Social and Administrative Pharmacy 2019;15(1):109 View
  20. Kaur K, Kanwal P, Goyal P, Singh P, Yakhmi S, Jain S, Kaushal S. Spontaneous Adverse Drug Reaction Monitoring in a Tertiary Care Centre. Current Drug Safety 2020;15(3):215 View
  21. Patel R, Anupam Kumar Sachan , Sanjana Chaohan , Aarti Tiwari , Taruna Giri , Nitish , Abdul Samad Ansari , Rajeshwar Kumar Yadav , Ehraz Mehmood Siddiqui , Shivam Kumar Pandey , Bindu Singh Yadav , Nandini Chaudhary . Present era of drug safety in India: An overview. Journal of Pharmacovigilance and Drug Research 2021;2(1):1 View
  22. Gupte D, Pradhan S. Pharmacovigilance: Perspectives in India. Journal of Medical Academics 2021;3(2):59 View
  23. Rajpurohit P, Suva M, Rajpurohit H, Singh Y. Pharmacovigilance in generic Indian pharmaceutical industries - Need of the moment. Journal of Pharmacovigilance and Drug Research 2021;2(2):7 View

Books/Policy Documents

  1. Sharma R, Nandave M, Kumar A. Pharmacovigilance Essentials. View
  2. Sar S, Banerjee T, Baidya A, Saha S, Kumar A, Halder A, Ghosh M, Nasare V, Ghosh N. Role of Herbal Medicines. View
  3. Singh S, Rao A, Verma S. Preparedness for Future Pandemics. View
  4. Ajaykumar C. Treating Endocrine and Metabolic Disorders With Herbal Medicines. View
  5. Desai N, Pande S, Gholap A, Rana D, Salave S, Vora L. Advanced Vaccination Technologies for Infectious and Chronic Diseases. View
  6. Bhati V, Nandave M, Kumar A, Pandita D. Pharmacovigilance Essentials. View
  7. Sharma R, Nandave M, Kumar A. Pharmacovigilance Essentials. View
  8. Sharma P, Nandave M, Kumar A. Pharmacovigilance Essentials. View
  9. Ahmad S, Gupta A, Katiyar C. Evidence-Based Validation of Herbal Medicine. View